Enrofloxacin

WikiDoc Resources for Enrofloxacin
Articles
Most recent articles on Enrofloxacin Most cited articles on Enrofloxacin Review articles on Enrofloxacin Articles on Enrofloxacin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Enrofloxacin Images of Enrofloxacin Photos of Enrofloxacin Podcasts & MP3s on Enrofloxacin Videos on Enrofloxacin
Evidence Based Medicine
Cochrane Collaboration on Enrofloxacin Bandolier on Enrofloxacin TRIP on Enrofloxacin
Clinical Trials
Ongoing Trials on Enrofloxacin at Clinical Trials.gov Trial results on Enrofloxacin Clinical Trials on Enrofloxacin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Enrofloxacin NICE Guidance on Enrofloxacin NHS PRODIGY Guidance FDA on Enrofloxacin CDC on Enrofloxacin
Books
Books on Enrofloxacin
News
Enrofloxacin in the news Be alerted to news on Enrofloxacin News trends on Enrofloxacin
Commentary
Blogs on Enrofloxacin
Definitions
Definitions of Enrofloxacin
Patient Resources / Community
Patient resources on Enrofloxacin Discussion groups on Enrofloxacin Patient Handouts on Enrofloxacin Directions to Hospitals Treating Enrofloxacin Risk calculators and risk factors for Enrofloxacin
Healthcare Provider Resources
Symptoms of Enrofloxacin Causes & Risk Factors for Enrofloxacin Diagnostic studies for Enrofloxacin Treatment of Enrofloxacin
Continuing Medical Education (CME)
CME Programs on Enrofloxacin
International
Enrofloxacin en Espanol Enrofloxacin en Francais
Business
Enrofloxacin in the Marketplace Patents on Enrofloxacin
Experimental / Informatics
List of terms related to Enrofloxacin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Enrofloxacin is a fluoroquinolone antibiotic sold by the Bayer Corporation under the trade name Baytril. Enrofloxacin is currently FDA-approved for treatment of individual pets and domestic animals in the United States. In September of 2005, the FDA withdrew approval of Baytril for use in water to treat flocks of poultry, as this practice was noted to promote the evolution of fluoroquinolone-resistant strains of the bacterium Campylobacter, a human pathogen. Fluoroquinolones such as ciprofloxacin are widely used in the treatment of human disease.